NASDAQ : MEDP

Medpace Holdings, Inc.

$589.37 USD

-$12.01 (-2.0%)

Volume
415.43K
Average Volume
348.23K
Market Capitalization
$16.45B
P/E Ratio
33.89
Dividend Yield
0.00%
Price Target
$600.00
Year High
$677.90
Year Low
$373.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.73
Company Overview

NASDAQ

August James Troendle

Medical - Diagnostics & Research

Healthcare

MEDP

6200

US

USD

https://www.medpace.com

513 579 9911

58506Q109

0001668397

Liquidity Metrics

0.28

0.73

0.73

0.35

0.00

Sales & Valuation

$2.53B

5.91

38.45

21.53

27.00

Profitability

$15.28

$451.12M

17.67%

21.53%

110.15%

23.89%

P/E Metrics

33.89

1.31

1.31

Analyst Price Target & Rating

$600.00

$692.00

$515.00

Neutral

3/5

19 Analysts

-1.77%

Financial Health Scores

7.93

7/9

-$385.14M

$2.06B

$1.62B

$588M

Key Metrics (TTM)

$16.4B

5.90

27.24

0.73

110.15%

77.00%

2.89%

4.55%

$77.38

51 days

Company Executives
Name Title
John T. Wynne Chief Business Officer
Stephen Ewald Chief Compliance Officer, General Counsel & Corporate Secretary
Susan E. Burwig Executive Vice President of Operations
Kevin Brady Chief Financial Officer & Treasurer
Lauren Morris Associate Director of Investors Relations
Jesse J. Geiger President
August James Troendle CEO, President & Chairman
Brad W. Hansman Executive Vice President of Operations
Todd Meyers Vice President of Business Development & Marketing
Weimin Gai Senior Vice President of Biometrics
Gina Leisring Senior Vice President of Clinical Monitoring
Reinilde Heyrman Chief Medical Officer of Medical Department
Poll Results

No votes yet today — be the first to share your view!

About Medpace Holdings, Inc. (NASDAQ:MEDP) Stock

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermor ... e, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.

3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)

2026-07-27 13:46:11

Medpace (MEDP) could produce exceptional returns because of its solid growth attributes.

Dimensional Fund Advisors LP Sells 10,865 Shares of Medpace Holdings, Inc. $MEDP

2026-07-26 03:49:51

Dimensional Fund Advisors LP cut its position in Medpace Holdings, Inc. (NASDAQ: MEDP) by 3.0% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 348,485 shares of the company's stock after selling 10,865 shares during the period. Dimensional Fund Advisors LP owned about

Medpace: Cancellations Are Normalizing

2026-07-25 07:16:25

Medpace Holdings demonstrates strong Q2 2026 net new business awards, with a 1.13x net book-to-bill and $3.0B backlog. Oncology bookings are robust, while cardiometabolic awards have declined; management expects mix normalization over the next year. Guidance is lifted on improved RFP trends, biotech funding breadth, and moderated cancellations, supporting growth momentum into 2027.

Arrowstreet Capital Limited Partnership Raises Stock Position in Medpace Holdings, Inc. $MEDP

2026-07-25 03:43:26

Arrowstreet Capital Limited Partnership grew its holdings in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) by 5.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 395,769 shares of the company's stock after buying an additional 20,736 shares during the quarter. Arrowstreet

Medpace Holdings, Inc. (MEDP) Hit a 52 Week High, Can the Run Continue?

2026-07-24 10:16:20

Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Medpace Soars After Q2 Beat, Strong Backlog Fuels Higher 2026 Outlook

2026-07-23 14:15:41

Medpace Holdings Inc. (NASDAQ:MEDP) stock is trading higher on Thursday on better-than-expected second-quarter financial results and raised its fiscal 2026 guidance.

Medpace: 'Buy' On Financial Metric Improvements And Solid Q2 2026 Earnings

2026-07-23 12:47:00

Medpace Holdings remains a "Buy" as Q2 2026 showed broad metric improvement and an inflection point in growth trajectory. The company's net book-to-Bill ratio rebounded to 1.13x, and backlog conversion rate rose to 24.1%, signaling strong future revenue visibility. Revenue grew 17.2% YoY to $707.3M, with EPS of $4.25 beating expectations; full-year 2026 guidance was raised to $2.805B–$2.885B.

Medpace Holdings, Inc. (MEDP) Q2 2026 Earnings Call Transcript

2026-07-23 12:20:29

Medpace Holdings, Inc. (MEDP) Q2 2026 Earnings Call Transcript

Frequently Asked Questions

What is the current Medpace Holdings, Inc. (MEDP) stock price?

Medpace Holdings, Inc.(NASDAQ:MEDP) stock price is $589.37 in the last trading session. During the trading session, MEDP stock reached the peak price of $677.9 while $373 was the lowest point it dropped to. The percentage change in MEDP stock occurred in the recent session was --2.0% while the dollar amount for the price change in MEDP stock was -$12.01.

MEDP's industry and sector of operation?

The NASDAQ listed MEDP is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of MEDP?

John T. Wynne | Chief Business Officer
Stephen Ewald | Chief Compliance Officer, General Counsel & Corporate Secretary
Susan E. Burwig | Executive Vice President of Operations
Kevin Brady | Chief Financial Officer & Treasurer
Lauren Morris | Associate Director of Investors Relations

How many employees does MEDP have?

Number of MEDP employees currently stands at 6200. MEDP operates from 5375 Medpace Way, Cincinnati, OH 45227, US.

Link for MEDP official website?

Official Website of MEDP is: https://www.medpace.com

How do I contact MEDP?

MEDP could be contacted at phone #513 579 9911 and can also be accessed through its website. MEDP operates from 5375 Medpace Way, Cincinnati, OH 45227, US.

How many shares of MEDP are traded daily?

The average number of MEDP shares traded daily for last 3 months was 348.23K.

What is the market cap of MEDP currently?

The market value of MEDP currently stands at $16.45B with its latest stock price at $589.37